RecruitingPhase 2NCT07323654
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Sponsor: Kymera Therapeutics, Inc.
Chattanooga, TN · +33 more sites
1 recruiting asthma studies with a site in Chattanooga, TN.
Sponsor: Kymera Therapeutics, Inc.
Chattanooga, TN · +33 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.